A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection

High Horn’s index score predicts poor outcomes in patients with Clostridium difficile infection

(2011) V. Arora et al.   JOURNAL OF HOSPITAL INFECTION

Fidaxomicin versus Vancomycin forClostridium difficileInfection

(2011) Thomas J. Louie et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation

(2011) Mark Pimentel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rifaximin: a nonsystemic rifamycin antibiotic for gastrointestinal infections

(2010) Jessica Cottreau et al.   Expert Review of Anti-Infective Therapy

Clostridium difficileinfection: update on emerging antibiotic treatment options and antibiotic resistance

(2010) Dhara Shah et al.   Expert Review of Anti-Infective Therapy

In vitro susceptibility of Clostridium difficile to rifaximin and rifampin in 359 consecutive isolates at a university hospital in Houston, Texas

(2010) Z-D Jiang et al.   JOURNAL OF CLINICAL PATHOLOGY

Increased rate of irritable bowel syndrome and functional gastrointestinal disorders after Clostridium difficile infection

(2010) S. Sethi et al.   JOURNAL OF HOSPITAL INFECTION

Treatment with Monoclonal Antibodies againstClostridium difficileToxins

(2010) Israel Lowy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rifaximin Redux: Treatment of recurrent Clostridium difficile infections with Rifaximin immediately post-vancomycin treatment

(2009) Stuart Johnson et al.   ANAEROBE

Pretreatment of Epithelial Cells with Rifaximin Alters Bacterial Attachment and Internalization Profiles

(2009) E. L. Brown et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

High Frequency of Rifampin Resistance Identified in an EpidemicClostridium difficileClone from a Large Teaching Hospital

(2009) Scott R. Curry et al.   CLINICAL INFECTIOUS DISEASES

Rifaximin in Treatment of Recurrent Clostridium difficile-associated Diarrhea: An Uncontrolled Pilot Study

(2008) Kevin W. Garey et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Clostridium difficile— More Difficult Than Ever

(2008) Ciarán P. Kelly et al.   NEW ENGLAND JOURNAL OF MEDICINE